APO Research
Talk to an analyst

APO RESEARCH · REPORT

Muscarinic Acetylcholine Receptor M4

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Muscarinic Acetylcholine Receptor M4 Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchMuscarinic Acetylcholine Receptor M4 Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Muscarinic Acetylcholine Receptor M4 Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Muscarinic Acetylcholine Receptor M4 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Muscarinic Acetylcholine Receptor M4 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Muscarinic Acetylcholine Receptor M4 Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Muscarinic Acetylcholine Receptor M4 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Muscarinic Acetylcholine Receptor M4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Muscarinic Acetylcholine Receptor M4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Muscarinic Acetylcholine Receptor M4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Muscarinic Acetylcholine Receptor M4 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Muscarinic Acetylcholine Receptor M4 include Sumitomo Dainippon Pharma Co Ltd, AstraZeneca Plc, NeuroHealing Pharmaceuticals Inc, Karuna Pharmaceuticals Inc, Heptares Therapeutics Ltd and Anavex Life Sciences Corp, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Muscarinic Acetylcholine Receptor M4, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Muscarinic Acetylcholine Receptor M4, also provides the sales of main regions and countries. Of the upcoming market potential for Muscarinic Acetylcholine Receptor M4, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Muscarinic Acetylcholine Receptor M4 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Muscarinic Acetylcholine Receptor M4 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Muscarinic Acetylcholine Receptor M4 sales, projected growth trends, production technology, application and end-user industry.

Muscarinic Acetylcholine Receptor M4 Segment by Company

Sumitomo Dainippon Pharma Co Ltd

AstraZeneca Plc

NeuroHealing Pharmaceuticals Inc

Karuna Pharmaceuticals Inc

Heptares Therapeutics Ltd

Anavex Life Sciences Corp

Muscarinic Acetylcholine Receptor M4 Segment by Type

Tropicamide

VU-0467154

ANAVEX-273

Others

Muscarinic Acetylcholine Receptor M4 Segment by Application

Amnesia

Cognitive Disorders

Psychosis

Others

Muscarinic Acetylcholine Receptor M4 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Muscarinic Acetylcholine Receptor M4 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Muscarinic Acetylcholine Receptor M4 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Muscarinic Acetylcholine Receptor M4.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Muscarinic Acetylcholine Receptor M4 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Muscarinic Acetylcholine Receptor M4 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Muscarinic Acetylcholine Receptor M4 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Muscarinic Acetylcholine Receptor M4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tropicamide Major Manufacturers Table 3. VU-0467154 Major Manufacturers Table 4. ANAVEX-273 Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Muscarinic Acetylcholine Receptor M4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Amnesia Major Manufacturers Table 8. Cognitive Disorders Major Manufacturers Table 9. Psychosis Major Manufacturers Table 10. Others Major Manufacturers Table 11. Muscarinic Acetylcholine Receptor M4 Industry Trends Table 12. Muscarinic Acetylcholine Receptor M4 Industry Drivers Table 13. Muscarinic Acetylcholine Receptor M4 Industry Opportunities and Challenges Table 14. Muscarinic Acetylcholine Receptor M4 Industry Restraints Table 15. Global Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Muscarinic Acetylcholine Receptor M4 Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Muscarinic Acetylcholine Receptor M4 Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region (2021-2026) Table 19. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region (2027-2032) Table 20. Global Muscarinic Acetylcholine Receptor M4 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 21. Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2021-2026) & (W Units) Table 22. Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2027-2032) & (W Units) Table 23. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2021-2026) Table 24. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2027-2032) Table 25. Global Muscarinic Acetylcholine Receptor M4 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Muscarinic Acetylcholine Receptor M4 Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Manufacturers (2021-2026) Table 29. Global Muscarinic Acetylcholine Receptor M4 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 30. Global Muscarinic Acetylcholine Receptor M4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Muscarinic Acetylcholine Receptor M4 Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Muscarinic Acetylcholine Receptor M4 Manufacturers, Product Type & Application Table 33. Global Muscarinic Acetylcholine Receptor M4 Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Muscarinic Acetylcholine Receptor M4 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Muscarinic Acetylcholine Receptor M4 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2021-2026) Table 40. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2027-2032) Table 41. Global Muscarinic Acetylcholine Receptor M4 Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 42. Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 43. Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 44. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2021-2026) Table 45. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2027-2032) Table 46. Global Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2026) & (US$/Unit) Table 47. Global Muscarinic Acetylcholine Receptor M4 Price by Type (2027-2032) & (US$/Unit) Table 48. Global Muscarinic Acetylcholine Receptor M4 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2021-2026) Table 52. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2027-2032) Table 53. Global Muscarinic Acetylcholine Receptor M4 Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 54. Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 55. Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 56. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2021-2026) Table 57. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2027-2032) Table 58. Global Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2026) & (US$/Unit) Table 59. Global Muscarinic Acetylcholine Receptor M4 Price by Application (2027-2032) & (US$/Unit) Table 60. Sumitomo Dainippon Pharma Co Ltd Company Information Table 61. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 62. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 63. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 64. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 65. AstraZeneca Plc Company Information Table 66. AstraZeneca Plc Business Overview Table 67. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 69. AstraZeneca Plc Recent Development Table 70. NeuroHealing Pharmaceuticals Inc Company Information Table 71. NeuroHealing Pharmaceuticals Inc Business Overview Table 72. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 74. NeuroHealing Pharmaceuticals Inc Recent Development Table 75. Karuna Pharmaceuticals Inc Company Information Table 76. Karuna Pharmaceuticals Inc Business Overview Table 77. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 79. Karuna Pharmaceuticals Inc Recent Development Table 80. Heptares Therapeutics Ltd Company Information Table 81. Heptares Therapeutics Ltd Business Overview Table 82. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 84. Heptares Therapeutics Ltd Recent Development Table 85. Anavex Life Sciences Corp Company Information Table 86. Anavex Life Sciences Corp Business Overview Table 87. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Portfolio Table 89. Anavex Life Sciences Corp Recent Development Table 90. North America Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 91. North America Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 92. North America Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 93. North America Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 94. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2021-2026) & (US$/Unit) Table 95. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2027-2032) & (US$/Unit) Table 96. North America Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 99. North America Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 100. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2021-2026) & (US$/Unit) Table 101. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2027-2032) & (US$/Unit) Table 102. North America Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. North America Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. North America Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. North America Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 106. North America Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026) & (W Units) Table 107. North America Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032) & (W Units) Table 108. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2021-2026) & (US$/Unit) Table 109. North America Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2027-2032) & (US$/Unit) Table 110. United States Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 111. Canada Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 112. Europe Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 115. Europe Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 116. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2021-2026) & (US$/Unit) Table 117. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2027-2032) & (US$/Unit) Table 118. Europe Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 121. Europe Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 122. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2021-2026) & (US$/Unit) Table 123. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2027-2032) & (US$/Unit) Table 124. Europe Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Europe Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 126. Europe Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 127. Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 128. Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026) & (W Units) Table 129. Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032) & (W Units) Table 130. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2021-2026) & (US$/Unit) Table 131. Europe Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2027-2032) & (US$/Unit) Table 132. Germany Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 133. France Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 134. U.K. Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 135. Italy Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 137. Nordic Countries Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 138. China Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 139. China Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 140. China Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 141. China Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 142. China Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2021-2026) & (US$/Unit) Table 143. China Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2027-2032) & (US$/Unit) Table 144. China Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 145. China Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 146. China Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 147. China Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 148. China Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2021-2026) & (US$/Unit) Table 149. China Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2027-2032) & (US$/Unit) Table 150. Asia Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 151. Asia Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 152. Asia Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 153. Asia Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 154. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2021-2026) & (US$/Unit) Table 155. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2027-2032) & (US$/Unit) Table 156. Asia Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 157. Asia Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 158. Asia Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 159. Asia Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 160. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2021-2026) & (US$/Unit) Table 161. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2027-2032) & (US$/Unit) Table 162. Asia Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. Asia Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 164. Asia Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 165. Asia Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 166. Asia Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026) & (W Units) Table 167. Asia Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032) & (W Units) Table 168. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2021-2026) & (US$/Unit) Table 169. Asia Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2027-2032) & (US$/Unit) Table 170. Japan Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 171. South Korea Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 172. India Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 173. Australia Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 174. China Taiwan Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 175. Southeast Asia Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 176. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2026) & (US$ Million) Table 177. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Type (2027-2032) & (US$ Million) Table 178. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2026) & (W Units) Table 179. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Type (2027-2032) & (W Units) Table 180. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2021-2026) & (US$/Unit) Table 181. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Type (2027-2032) & (US$/Unit) Table 182. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2026) & (US$ Million) Table 183. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Application (2027-2032) & (US$ Million) Table 184. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2026) & (W Units) Table 185. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Application (2027-2032) & (W Units) Table 186. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2021-2026) & (US$/Unit) Table 187. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Application (2027-2032) & (US$/Unit) Table 188. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 189. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 190. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 191. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 192. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Country (2021-2026) & (W Units) Table 193. SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Country (2027-2032) & (W Units) Table 194. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2021-2026) & (US$/Unit) Table 195. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Price by Country (2027-2032) & (US$/Unit) Table 196. Brazil Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 197. Argentina Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 198. Chile Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 199. Colombia Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 200. Peru Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 201. Saudi Arabia Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 202. Israel Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 203. UAE Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 204. Turkey Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 205. Iran Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 206. Egypt Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Table 207. Key Raw Materials Table 208. Raw Materials Key Suppliers Table 209. Muscarinic Acetylcholine Receptor M4 Distributors List Table 210. Muscarinic Acetylcholine Receptor M4 Customers List Table 211. Research Programs/Design for This Report Table 212. Authors List of This Report Table 213. Secondary Sources Table 214. Primary Sources List of Figures Figure 1. Muscarinic Acetylcholine Receptor M4 Image Figure 2. Global Muscarinic Acetylcholine Receptor M4 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Muscarinic Acetylcholine Receptor M4 Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tropicamide Image Figure 5. VU-0467154 Image Figure 6. ANAVEX-273 Image Figure 7. Others Image Figure 8. Global Muscarinic Acetylcholine Receptor M4 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Muscarinic Acetylcholine Receptor M4 Market Size Share 2021 VS 2025 VS 2032 Figure 10. Amnesia Image Figure 11. Cognitive Disorders Image Figure 12. Psychosis Image Figure 13. Others Image Figure 14. Global Muscarinic Acetylcholine Receptor M4 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Muscarinic Acetylcholine Receptor M4 Revenue (2021-2032) & (US$ Million) Figure 16. Global Muscarinic Acetylcholine Receptor M4 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region (2021-2032) Figure 19. Global Muscarinic Acetylcholine Receptor M4 Sales (2021-2032) & (W Units) Figure 20. Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 21. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Muscarinic Acetylcholine Receptor M4 Sales YoY (2021-2032) & (W Units) Figure 23. Europe Muscarinic Acetylcholine Receptor M4 Sales YoY (2021-2032) & (W Units) Figure 24. China Muscarinic Acetylcholine Receptor M4 Sales YoY (2021-2032) & (W Units) Figure 25. Asia (Excluding China) Muscarinic Acetylcholine Receptor M4 Sales YoY (2021-2032) & (W Units) Figure 26. South America, Middle East and Africa Muscarinic Acetylcholine Receptor M4 Sales YoY (2021-2032) & (W Units) Figure 27. Global Muscarinic Acetylcholine Receptor M4 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Muscarinic Acetylcholine Receptor M4 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2021-2032) Figure 33. Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 34. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2021-2032) Figure 36. Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2021-2032) Figure 39. Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 40. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2021-2032) Figure 42. North America Muscarinic Acetylcholine Receptor M4 Revenue Share by Type (2021-2032) Figure 43. North America Muscarinic Acetylcholine Receptor M4 Sales Share by Type (2021-2032) Figure 44. North America Muscarinic Acetylcholine Receptor M4 Revenue Share by Application (2021-2032) Figure 45. North America Muscarinic Acetylcholine Receptor M4 Sales Share by Application (2021-2032) Figure 46. North America Muscarinic Acetylcholine Receptor M4 Revenue Share by Country (2021-2032) Figure 47. North America Muscarinic Acetylcholine Receptor M4 Sales Share by Country (2021-2032) Figure 48. Europe Muscarinic Acetylcholine Receptor M4 Revenue Share by Type (2021-2032) Figure 49. Europe Muscarinic Acetylcholine Receptor M4 Sales Share by Type (2021-2032) Figure 50. Europe Muscarinic Acetylcholine Receptor M4 Revenue Share by Application (2021-2032) Figure 51. Europe Muscarinic Acetylcholine Receptor M4 Sales Share by Application (2021-2032) Figure 52. Europe Muscarinic Acetylcholine Receptor M4 Revenue Share by Country (2021-2032) Figure 53. Europe Muscarinic Acetylcholine Receptor M4 Sales Share by Country (2021-2032) Figure 54. China Muscarinic Acetylcholine Receptor M4 Revenue Share by Type (2021-2032) Figure 55. China Muscarinic Acetylcholine Receptor M4 Sales Share by Type (2021-2032) Figure 56. China Muscarinic Acetylcholine Receptor M4 Revenue Share by Application (2021-2032) Figure 57. China Muscarinic Acetylcholine Receptor M4 Sales Share by Application (2021-2032) Figure 58. Asia Muscarinic Acetylcholine Receptor M4 Revenue Share by Type (2021-2032) Figure 59. Asia Muscarinic Acetylcholine Receptor M4 Sales Share by Type (2021-2032) Figure 60. Asia Muscarinic Acetylcholine Receptor M4 Revenue Share by Application (2021-2032) Figure 61. Asia Muscarinic Acetylcholine Receptor M4 Sales Share by Application (2021-2032) Figure 62. Asia Muscarinic Acetylcholine Receptor M4 Revenue Share by Country (2021-2032) Figure 63. Asia Muscarinic Acetylcholine Receptor M4 Sales Share by Country (2021-2032) Figure 64. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Share by Type (2021-2032) Figure 65. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Share by Type (2021-2032) Figure 66. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Share by Application (2021-2032) Figure 67. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Share by Application (2021-2032) Figure 68. SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Share by Country (2021-2032) Figure 69. SAMEA Muscarinic Acetylcholine Receptor M4 Sales Share by Country (2021-2032) Figure 70. Muscarinic Acetylcholine Receptor M4 Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Muscarinic Acetylcholine Receptor M4 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Tropicamide
  • VU-0467154
  • ANAVEX-273
  • Others
Applications
  • Amnesia
  • Cognitive Disorders
  • Psychosis
  • Others
Companies covered
  • Sumitomo Dainippon Pharma Co Ltd
  • AstraZeneca Plc
  • NeuroHealing Pharmaceuticals Inc
  • Karuna Pharmaceuticals Inc
  • Heptares Therapeutics Ltd
  • Anavex Life Sciences Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Muscarinic Acetylcholine Receptor M4 Market by Type
  3. 1.2.1 Global Muscarinic Acetylcholine Receptor M4 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tropicamide
  5. 1.2.3 VU-0467154
  6. 1.2.4 ANAVEX-273
  7. 1.2.5 Others
  8. 1.3 Muscarinic Acetylcholine Receptor M4 Market by Application
  9. 1.3.1 Global Muscarinic Acetylcholine Receptor M4 Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Amnesia
  11. 1.3.3 Cognitive Disorders
  12. 1.3.4 Psychosis
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Muscarinic Acetylcholine Receptor M4 Market Dynamics
  1. 2.1 Muscarinic Acetylcholine Receptor M4 Industry Trends
  2. 2.2 Muscarinic Acetylcholine Receptor M4 Industry Drivers
  3. 2.3 Muscarinic Acetylcholine Receptor M4 Industry Opportunities and Challenges
  4. 2.4 Muscarinic Acetylcholine Receptor M4 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Muscarinic Acetylcholine Receptor M4 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region
  3. 3.2.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region (2021-2026)
  5. 3.2.3 Global Muscarinic Acetylcholine Receptor M4 Revenue by Region (2027-2032)
  6. 3.2.4 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Muscarinic Acetylcholine Receptor M4 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Muscarinic Acetylcholine Receptor M4 Sales by Region
  9. 3.4.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2021-2026)
  11. 3.4.3 Global Muscarinic Acetylcholine Receptor M4 Sales by Region (2027-2032)
  12. 3.4.4 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Manufacturers
  2. 4.1.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Muscarinic Acetylcholine Receptor M4 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Manufacturers
  6. 4.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Muscarinic Acetylcholine Receptor M4 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Muscarinic Acetylcholine Receptor M4 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Muscarinic Acetylcholine Receptor M4 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Muscarinic Acetylcholine Receptor M4 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Muscarinic Acetylcholine Receptor M4 Manufacturers, Product Type & Application
  13. 4.7 Global Muscarinic Acetylcholine Receptor M4 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Muscarinic Acetylcholine Receptor M4 Market CR5 and HHI
  16. 4.8.2 2025 Muscarinic Acetylcholine Receptor M4 Tier 1, Tier 2, and Tier 3
5 Muscarinic Acetylcholine Receptor M4 Market by Type
  1. 5.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Type
  2. 5.1.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Type
  6. 5.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Muscarinic Acetylcholine Receptor M4 Price by Type
6 Muscarinic Acetylcholine Receptor M4 Market by Application
  1. 6.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Application
  2. 6.1.1 Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Muscarinic Acetylcholine Receptor M4 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Application
  6. 6.2.1 Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Muscarinic Acetylcholine Receptor M4 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Muscarinic Acetylcholine Receptor M4 Price by Application
7 Company Profiles
  1. 7.1 Sumitomo Dainippon Pharma Co Ltd
  2. 7.1.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  3. 7.1.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  4. 7.1.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
  6. 7.1.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  7. 7.2 AstraZeneca Plc
  8. 7.2.1 AstraZeneca Plc Company Information
  9. 7.2.2 AstraZeneca Plc Business Overview
  10. 7.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Plc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  12. 7.2.5 AstraZeneca Plc Recent Developments
  13. 7.3 NeuroHealing Pharmaceuticals Inc
  14. 7.3.1 NeuroHealing Pharmaceuticals Inc Company Information
  15. 7.3.2 NeuroHealing Pharmaceuticals Inc Business Overview
  16. 7.3.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  18. 7.3.5 NeuroHealing Pharmaceuticals Inc Recent Developments
  19. 7.4 Karuna Pharmaceuticals Inc
  20. 7.4.1 Karuna Pharmaceuticals Inc Company Information
  21. 7.4.2 Karuna Pharmaceuticals Inc Business Overview
  22. 7.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor M4 Product Portfolio
  24. 7.4.5 Karuna Pharmaceuticals Inc Recent Developments
  25. 7.5 Heptares Therapeutics Ltd
  26. 7.5.1 Heptares Therapeutics Ltd Company Information
  27. 7.5.2 Heptares Therapeutics Ltd Business Overview
  28. 7.5.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor M4 Product Portfolio
  30. 7.5.5 Heptares Therapeutics Ltd Recent Developments
  31. 7.6 Anavex Life Sciences Corp
  32. 7.6.1 Anavex Life Sciences Corp Company Information
  33. 7.6.2 Anavex Life Sciences Corp Business Overview
  34. 7.6.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor M4 Product Portfolio
  36. 7.6.5 Anavex Life Sciences Corp Recent Developments
8 North America
  1. 8.1 North America Muscarinic Acetylcholine Receptor M4 Market Size by Type
  2. 8.1.1 North America Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
  3. 8.1.2 North America Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
  4. 8.1.3 North America Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
  5. 8.2 North America Muscarinic Acetylcholine Receptor M4 Market Size by Application
  6. 8.2.1 North America Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
  7. 8.2.2 North America Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
  8. 8.2.3 North America Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
  9. 8.3 North America Muscarinic Acetylcholine Receptor M4 Market Size by Country
  10. 8.3.1 North America Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Muscarinic Acetylcholine Receptor M4 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Muscarinic Acetylcholine Receptor M4 Market Size by Type
  2. 9.1.1 Europe Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
  4. 9.1.3 Europe Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
  5. 9.2 Europe Muscarinic Acetylcholine Receptor M4 Market Size by Application
  6. 9.2.1 Europe Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
  8. 9.2.3 Europe Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
  9. 9.3 Europe Muscarinic Acetylcholine Receptor M4 Market Size by Country
  10. 9.3.1 Europe Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Muscarinic Acetylcholine Receptor M4 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Muscarinic Acetylcholine Receptor M4 Market Size by Type
  2. 10.1.1 China Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
  3. 10.1.2 China Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
  4. 10.1.3 China Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
  5. 10.2 China Muscarinic Acetylcholine Receptor M4 Market Size by Application
  6. 10.2.1 China Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
  7. 10.2.2 China Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
  8. 10.2.3 China Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Muscarinic Acetylcholine Receptor M4 Market Size by Type
  2. 11.1.1 Asia Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
  4. 11.1.3 Asia Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
  5. 11.2 Asia Muscarinic Acetylcholine Receptor M4 Market Size by Application
  6. 11.2.1 Asia Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
  8. 11.2.3 Asia Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
  9. 11.3 Asia Muscarinic Acetylcholine Receptor M4 Market Size by Country
  10. 11.3.1 Asia Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Muscarinic Acetylcholine Receptor M4 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Muscarinic Acetylcholine Receptor M4 Market Size by Type
  2. 12.1.1 SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Muscarinic Acetylcholine Receptor M4 Price by Type (2021-2032)
  5. 12.2 SAMEA Muscarinic Acetylcholine Receptor M4 Market Size by Application
  6. 12.2.1 SAMEA Muscarinic Acetylcholine Receptor M4 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Muscarinic Acetylcholine Receptor M4 Price by Application (2021-2032)
  9. 12.3 SAMEA Muscarinic Acetylcholine Receptor M4 Market Size by Country
  10. 12.3.1 SAMEA Muscarinic Acetylcholine Receptor M4 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Muscarinic Acetylcholine Receptor M4 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Muscarinic Acetylcholine Receptor M4 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Muscarinic Acetylcholine Receptor M4 Value Chain Analysis
  2. 13.1.1 Muscarinic Acetylcholine Receptor M4 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Muscarinic Acetylcholine Receptor M4 Production Mode & Process
  6. 13.2 Muscarinic Acetylcholine Receptor M4 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Muscarinic Acetylcholine Receptor M4 Distributors
  9. 13.2.3 Muscarinic Acetylcholine Receptor M4 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst